Literature DB >> 28734644

Postmastectomy radiation therapy technique and cardiopulmonary sparing: A dosimetric comparative analysis between photons and protons with free breathing versus deep inspiration breath hold.

Sagar A Patel1, Hsiao-Ming Lu2, Jacqueline A Nyamwanda2, Rachel B Jimenez2, Alphonse G Taghian2, Shannon M MacDonald2, Nicolas Depauw2.   

Abstract

PURPOSE: Dosimetric studies have suggested greater cardiopulmonary sparing with protons over photons for left-sided postmastectomy radiation therapy (PMRT). Modern techniques such as deep inspiration breath hold (DIBH) can help spare the heart. This analysis compares photon and proton delivery with and without DIBH. METHODS AND MATERIALS: Ten women with left breast cancer referred for PMRT on a prospective clinical trial with unfavorable cardiac anatomy underwent free breathing (FB) and DIBH computed tomography simulation. A partially wide tangent photon (PWTF) during DIBH, passively scattered proton during FB, pencil-beam scanning (PBS) proton during FB, and PBS proton during DIBH plan was completed for each patient. Plans were designed to achieve 95% prescription dose coverage to 95% of chest wall and regional lymphatics while maximally sparing heart and lungs.
RESULTS: All techniques resulted in similar target coverage, although protons improved homogeneity indices and cardiopulmonary sparing (omnibus P < .0001 for each metric). Heart/lung metrics for PWTF with DIBH, scattered protons with FB, PBS protons with FB, and PBS protons with DIBH, respectively, were as follows: mean heart dose (2.09, 0.39, 0.98, 0.71 Gy relative biological effectiveness [RBE]), mean left ventricle dose (3.72, 0.08, 0.19, 0.21 GyRBE), V20 left ventricle (2.73, 0.03, 0, 0%), maximum left anterior descending artery dose (46.14, 8.28, 4.58, 4.63 GyRBE), mean lung dose (13.30, 5.74, 7.63, 7.49 GyRBE), and V20 lung (26.04, 12.04, 15.18, 14.43 %). Pairwise testing confirmed an improvement in each metric with all proton plans compared with PWTF with DIBH; there were no differences in homogeneity indices or cardiopulmonary sparing between passively scattered and PBS protons, regardless of addition of DIBH.
CONCLUSIONS: For left-sided PMRT, passively scattered or PBS protons with or without DIBH improves homogeneity and cardiopulmonary sparing without compromise in target coverage compared with PWTF photons with DIBH. Furthermore, the addition of DIBH to proton therapy did not provide a significant dosimetric benefit.
Copyright © 2017 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28734644     DOI: 10.1016/j.prro.2017.06.006

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  18 in total

Review 1.  Proton Therapy for Primary Breast Cancer.

Authors:  Eugen B Hug
Journal:  Breast Care (Basel)       Date:  2018-06-15       Impact factor: 2.860

Review 2.  The impact of proton therapy on cardiotoxicity following radiation treatment.

Authors:  Andrew J Frankart; Rajaram Nagarajan; Luke Pater
Journal:  J Thromb Thrombolysis       Date:  2020-10-08       Impact factor: 2.300

3.  Health care costs for adolescents and young adults with cancer: a Wisconsin community-based hospital study between 2005 and 2020.

Authors:  Kekoa Taparra; Alec Fitzsimmons; Susan Frankki; Andrea De Wall; Fumiko Chino; Antoinette Peters
Journal:  Support Care Cancer       Date:  2021-09-26       Impact factor: 3.359

Review 4.  Deep Inspiration Breath Hold: Techniques and Advantages for Cardiac Sparing During Breast Cancer Irradiation.

Authors:  Carmen Bergom; Adam Currey; Nina Desai; An Tai; Jonathan B Strauss
Journal:  Front Oncol       Date:  2018-04-04       Impact factor: 6.244

5.  Is Proton Therapy a "Pro" for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.

Authors:  Mudit Chowdhary; Anna Lee; Sarah Gao; Dian Wang; Parul N Barry; Roberto Diaz; Neeti R Bagadiya; Henry S Park; James B Yu; Lynn D Wilson; Meena S Moran; Susan A Higgins; Christin A Knowlton; Kirtesh R Patel
Journal:  Front Oncol       Date:  2019-01-14       Impact factor: 6.244

Review 6.  New frontiers in proton therapy: applications in cancers.

Authors:  Tai-Ze Yuan; Ze-Jiang Zhan; Chao-Nan Qian
Journal:  Cancer Commun (Lond)       Date:  2019-10-22

7.  Two-Level Factorial Pre-TomoBreast Pilot Study of Tomotherapy and Conventional Radiotherapy in Breast Cancer: Post Hoc Utility of a Mean Absolute Dose Deviation Penalty Score.

Authors:  Steve Heymann; Giovanna Dipasquale; Nam P Nguyen; Meymey San; Olena Gorobets; Nicolas Leduc; Dirk Verellen; Guy Storme; Hilde Van Parijs; Mark De Ridder; Vincent Vinh-Hung
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 8.  Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy.

Authors:  Marika Musielak; Wiktoria M Suchorska; Magdalena Fundowicz; Piotr Milecki; Julian Malicki
Journal:  J Pers Med       Date:  2021-05-13

Review 9.  Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.

Authors:  Robert W Mutter; J Isabelle Choi; Rachel B Jimenez; Youlia M Kirova; Marcio Fagundes; Bruce G Haffty; Richard A Amos; Julie A Bradley; Peter Y Chen; Xuanfeng Ding; Antoinette M Carr; Leslie M Taylor; Mark Pankuch; Raymond B Mailhot Vega; Alice Y Ho; Petra Witt Nyström; Lisa A McGee; James J Urbanic; Oren Cahlon; John H Maduro; Shannon M MacDonald
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-05-25       Impact factor: 8.013

10.  The Lack of Consensus of International Contouring Guidelines for the Dorsal Border of the Chest Wall Clinical Target Volume: What is the Impact on Organs at Risk and Relationships to Patterns of Recurrence in the Modern Era?

Authors:  Phillip M Pifer; Robert P Bice; Geraldine M Jacobson; Kristin Lupinacci; Sushil Beriwal; Hannah W Hazard; John A Vargo
Journal:  Adv Radiat Oncol       Date:  2018-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.